Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 11:31 p.m.	usa	The safety of the candidate therapies in COVID-19 patients by measuring physiological changes in the circulatory and respiratory system.;The safety of the candidate therapies in COVID-19 patients by recording the number of treatment related adverse events.	The safety of the candidate therapies in COVID-19 patients by measuring physiological changes in the circulatory and respiratory system.;The safety of the candidate therapies in COVID-19 patients by recording the number of treatment related adverse events.